Working Market for Patients Living With Advanced Breast Cancer in Portugal: Call for Action

Author(s)

Borges M1, Silva Miguel L2, Oliveira T1, Bulhosa C1, Matos L3, Pinheiro B4, Fidalgo Freitas T5, Cardoso F3
1IQVIA Portugal, Lisbon, Portugal, 2IQVIA Portugal, Salvo, Oeiras, 13, Portugal, 3Champalimaud Clinical Centre, Lisbon, Portugal, 4IQVIA Portugal, Lisboa, Portugal, 5Universidade de Lisboa, Lisboa, PORTUGAL, Portugal

OBJECTIVES: This study aims to quantify the productivity costs of premature abandonment of work market of women living with advanced breast cancer (ABC) as well as to evaluate possible labour market policies designed to promote employment

METHODS: The analysis is based on (i) an original cumulative incidence model that allows estimation of the prevalence of working-aged women with ABC in 2019 and on (ii) an observational study that characterises the employment status and working conditions of patients with ABC in Portugal. To determine productivity costs, the human capital approach was adopted.

RESULTS: A total of 2,151 working-aged women were estimated to have ABC in 2019, with productivity costs amounting to 28,676,754€ over the period 2019-2021. Moreover, government transfers (unemployment subsidies and disability pensions) were estimated to be 3,468,866€.

A subsidised part-time employment policy designed to encourage women with ABC to continue working was modelled. The estimated increased cost of this policy is 11,951,048€ over a three-year period, allowing a reduction of 14,338,377€ in productivity costs, leading to a positive balance of 2,431,329€ over the same period.

CONCLUSIONS: These results call for changes in labour market laws to enable all patients living with metastatic cancers the right to choose part-time and/or flexible working, without depending on the employer permission as currently stated in the law.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

HPR52

Topic

Health Policy & Regulatory

Topic Subcategory

Public Spending & National Health Expenditures

Disease

No Additional Disease & Conditions/Specialized Treatment Areas, Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×